Noubar Afeyan sold $434K of Moderna (MRNA)

Executed May 21, disclosed May 22, 1 day later.

Value, as filed

$434K

9,263 sh × $46.84

Executed

May 21

the trade date, as filed

Disclosed

May 22

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

NA Noubar Afeyan Director profile →

Noubar Afeyan (Director) filed 4 Form 4 reports in the trailing twelve months (2 purchases, 2 sales), most often in GENB. Across 2 priced purchase filings, the average 21-session return was -4.2% from execution and -4.2% from disclosure (delay-adjusted; derived). The largest single filing was $75.0M of GENB (4,687,500 sh across 3 lots, as filed), executed Mar 2.

The name

MRNA

Moderna, Inc. MRNA · Healthcare · 18 filings in 24 months ticker →

Healthcare · Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Noubar Afeyan in MRNA

MRNASALE Moderna, Inc. $703K
23,853 sh × $29.49
Exec Dec 11 2025
Filed Dec 15 2025 · 5:30 PM ET